Quest Diagnostics Incorporated (DGX) vs United Therapeutics Corporation (UTHR)
A side-by-side comparison of Quest Diagnostics Incorporated and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.
DGX
Quest Diagnostics Incorporated
$241.76HealthcareAt close: Aug 19, 2026, 4:00 PM ET
UTHR
United Therapeutics Corporation
$529.14HealthcareAt close: Aug 19, 2026, 4:00 PM ET
Total return — DGX vs UTHR
growth of $100 · dividends reinvested · last 10yDGX +246.0% (+13.2%/yr)UTHR +322.6% (+15.5%/yr)UTHR compounded faster over this window
DGX UTHR
DGX vs UTHR: by the numbers
- •DGX is the larger company ($26.68B vs $22.46B market cap).
- •UTHR trades at the lower trailing earnings multiple (18.96 vs 25.66 P/E), one valuation lens rather than an overall verdict.
- •UTHR converts more revenue to profit (41.56% vs 9.19% net margin).
- •UTHR grew revenue faster over the past five years (14.68% vs 0.89% CAGR).
- •DGX pays a dividend (1.37% yield), while UTHR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | DGX | UTHR |
|---|---|---|
| P/E ratio | 25.66 | 18.96 |
| Forward P/E | 21.60 | 20.07 |
| P/S ratio | 2.34 | 7.68 |
| P/B ratio | 3.60 | 3.79 |
| EV / EBITDA | 16.44 | 15.01 |
| FCF yield | 4.51% | 4.51% |
Profitability
| Metric | DGX | UTHR |
|---|---|---|
| Gross margin | 33.15% | 86.14% |
| Operating margin | 14.14% | 44.49% |
| Net margin | 9.19% | 41.56% |
| ROE | 14.13% | 20.48% |
| ROIC | 8.25% | 17.69% |
Dividends
| Metric | DGX | UTHR |
|---|---|---|
| Dividend yield | 1.37% | N/A |
| Payout ratio | 37.43% | N/A |
Growth (annualized)
| Metric | DGX | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | 0.89% | 14.68% |
| EPS CAGR (5Y) | -3.65% | 20.93% |
| FCF CAGR (5Y) | -10.89% | 14.31% |
| Total return CAGR (5Y) | 11.94% | 21.36% |
Frequently asked
- Which has the lower trailing P/E, DGX or UTHR?
- UTHR has the lower trailing P/E: DGX trades at 25.66 and UTHR at 18.96. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, DGX or UTHR?
- Over the past five years, UTHR grew revenue faster — DGX at a 0.89% CAGR versus UTHR at 14.68%.
- Does DGX or UTHR pay a bigger dividend?
- DGX pays a dividend (1.37% yield), while UTHR has no payments in the available dividend history.
- Is DGX or UTHR more profitable?
- UTHR runs the higher net margin — DGX at 9.19% versus UTHR at 41.56%.
- How have DGX and UTHR total returns compared?
- Over the past 10 years, DGX delivered 13.24% and UTHR delivered 15.35% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Quest Diagnostics P/E ratioUnited Therapeutics P/E ratioQuest Diagnostics dividend yieldQuest Diagnostics ROEUnited Therapeutics ROEQuest Diagnostics operating marginUnited Therapeutics operating marginQuest Diagnostics revenue growthUnited Therapeutics revenue growthQuest Diagnostics free cash flowUnited Therapeutics free cash flow
Quest Diagnostics & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.